Too Sensitive or Just Right?


Journal

American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470

Informations de publication

Date de publication:
04 08 2022
Historique:
received: 27 10 2021
accepted: 14 03 2022
pubmed: 29 4 2022
medline: 6 8 2022
entrez: 28 4 2022
Statut: ppublish

Résumé

To compare the performance of the rabbit monoclonal antihuman CD246 antibody (D5F3 clone) with the established ALK1 clone for immunohistochemical assessment of anaplastic large cell lymphoma (ALCL). Archival cases of ALCL (n = 27) were assessed immunohistochemically by use of ALK1 and D5F3 clones under standard Clinical Laboratory Improvement Amendments-compliant conditions. The intensity of cytoplasmic staining (0 = none; 1 = faint; 2 = moderate; 3+ = strong) and proportion of neoplastic cells (0%, <5%, 5%-50%, >50%) were evaluated and compared with clinical ALK break-apart fluorescence in situ hybridization (FISH) assays. Nine ALCL specimens were positive for ALK expression by ALK1 staining (33%; 1 = 1+; 0 = 2+; 8 = 3+), while 14 were positive by D5F3 staining (48%; 3 = 1+; 1 = 2+; 10 = 3+). Across the cohort, D5F3 staining showed a significantly greater proportion of cells staining positive (P = .02) and greater intensity (P = .03). Of 3 cases positive for D5F3 only with FISH results, none showed rearrangements, although 1 showed copy number gains at the ALK locus in a subset of cells. Overall, D5F3 showed greater stain intensity and proportion staining than ALK1 in ALK-positive ALCL cases, which is especially helpful in limited samples. Caution and consideration of orthogonal ALK testing types is recommended, especially for cases with weak or focal staining.

Identifiants

pubmed: 35482487
pii: 6575481
doi: 10.1093/ajcp/aqac043
doi:

Substances chimiques

Antibodies, Monoclonal 0
Anaplastic Lymphoma Kinase EC 2.7.10.1
Receptor Protein-Tyrosine Kinases EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-290

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Dana Martin (D)

Department of Pathology, Virginia Commonwealth University (VCU) School of Medicine, Richmond, VA, USA.

Steven C Smith (SC)

Department of Pathology, Virginia Commonwealth University (VCU) School of Medicine, Richmond, VA, USA.
Department of Surgery, Virginia Commonwealth University (VCU) School of Medicine, Richmond, VA, USA.

Alden Chesney (A)

Department of Pathology, Virginia Commonwealth University (VCU) School of Medicine, Richmond, VA, USA.

Colleen Jackson-Cook (C)

Department of Pathology, Virginia Commonwealth University (VCU) School of Medicine, Richmond, VA, USA.
Department of Human and Molecular Genetics, VCU Health, Richmond, VA, USA.

Raghavendra Pillappa (R)

Department of Pathology, Virginia Commonwealth University (VCU) School of Medicine, Richmond, VA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH